Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A syngeneic MC38 orthotopic mouse model of colorectal cancer metastasis
Joshua D. Greenlee, Michael R. King
Biology Methods and Protocols (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Orthotopic and metastatic tumour models in preclinical cancer research
Stephen M. Stribbling, Callum Beach, Anderson J. Ryan
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108631-108631
Open Access | Times Cited: 17
Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos
Sicong Ma, Roger Sandhoff, Xiu Luo, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Closed Access | Times Cited: 15
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer
Kento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3787-3802
Open Access | Times Cited: 18
Experimental Murine Models for Colorectal Cancer Research
Íris Neto, João Rocha, Maria Manuela Gaspar, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2570-2570
Open Access | Times Cited: 14
Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody
Yunqi Yao, Xiaoning Yang, Jing Li, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 395-395
Open Access
The Novel Dual GIP and GLP‐1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism
Yikai Zhang, Yi Xie, Shenglong Xia, et al.
Advanced Science (2025)
Open Access
Tumor-driven stromal reprogramming in the pre-metastatic lymph node
Michelle Piquet, David A. Ruddy, Viviana Cremasco, et al.
F1000Research (2025) Vol. 13, pp. 223-223
Open Access
TRAIL‐conjugated liposomes that bind natural killer cells to induce colorectal cancer cell apoptosis
Joshua D. Greenlee, Zhenjiang Zhang, Tejas Subramanian, et al.
Journal of Biomedical Materials Research Part A (2023) Vol. 112, Iss. 1, pp. 110-120
Open Access | Times Cited: 11
Model systems to study tumor-microbiome interactions in early-onset colorectal cancer
Katharina Maria Richter, Marius Wrage, Carolin Krekeler, et al.
EMBO Molecular Medicine (2025)
Open Access
SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species
Sangeetha Srinivasan, Nathan A. Yee, Michael Zakharian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
The Function of the Immune System, Beyond Strategies Based on Cell‐Autonomous Mechanisms, Determines Cancer Development: Immune Response and Cancer Development
Hamid Zand, Katayoun Pourvali
Advanced Biology (2024) Vol. 8, Iss. 4
Closed Access | Times Cited: 2
WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations
Misa Ariyoshi, Ryo Yuge, Yuki Kitadai, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3136-3136
Open Access | Times Cited: 1
RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer
Xuefei Zhou, Dezhi Li, Shenglong Xia, et al.
Journal of Controlled Release (2023) Vol. 366, pp. 128-141
Closed Access | Times Cited: 3
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
Yurong Song, Travis Kerr, Chelsea Sanders, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Deciphering the Biological Assays to Elucidate the Potential of Bioactive Molecules
Anjali Saxena, S. Biswas, Biswajit Saha
(2024)
Closed Access
Correlation between abdominal computed tomography signs and postoperative prognosis for patients with colorectal cancer
Shaomin Yang, Jiemei Liu, Rui-Ping Wen, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 7, pp. 2145-2156
Open Access
Enhanced Proteomic Coverage in Tissue Microenvironment by Immune Cell Subtype Library-assisted DIA-MS
Jhih‐Ci Yang, Tzi-Hui Hsu, Ciao‐Syuan Chen, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 7, pp. 100792-100792
Open Access
nsGSLs on tumors impair anti-tumor immune responses by OT-I T cells in vitro and support tumor growth in vivo
Tamara Verkerk, Aimée A.F. Selten, Nordin D. Zandhuis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome
Kento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward
Deepak Kumar Mishra, Dean Popovski, Shelli M. Morris, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 226-235
Open Access | Times Cited: 1
Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer
Robert G. Ramsay, Vicki Whitehall, Michael P. Flood
Growth Factors (2023) Vol. 41, Iss. 4, pp. 179-191
Closed Access
Page 1

Scroll to top